Hyaluronic Acid Vancomycin Coating for Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implant devices face challenges in preventing periprosthetic infections due to bacterial adhesion and biofilm formation, with existing antibiotic release systems being complex and not suitable for industrial production, and lacking effective osteointegration properties.
Innovation Solution
A process that immobilizes vancomycin on implant surfaces through a hyaluronic acid/vancomycin complex, using cross-linking agents to form a stable, slow-release antibiotic layer that enhances osteointegration and prevents bacterial colonization, applicable to various implant materials and geometries.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If local release systems using porous cements or biodegradable polymers are used to release antibiotics, then antibacterial activity is improved, but the porous structures serve as protected sites for bacterial adhesion and biofilm formation after antibiotic release
Solution Approach 1:
The surface is segmented into multiple functional layers: a base layer for structural integrity, an intermediate layer for antibiotic release, and a top layer with osteoinductive properties. This segmentation allows each layer to perform its specific function without compromising the others, preventing the porous structure from becoming a bacterial sanctuary.
Solution Approach 2:
The patent modifies the surface parameters by controlling porosity distribution, pore size, and surface roughness to optimize both antibiotic release kinetics and osteointegration. By carefully adjusting these parameters, the surface maintains antibacterial efficacy while promoting bone growth and preventing biofilm formation.
2Object-affected harmful factors
If complex multi-step processes are used to bond antibiotics to implant surfaces, then antibacterial efficacy is improved, but manufacturing complexity and industrial adaptability worsen
Solution Approach 1:
The patent combines multiple functions into a single integrated coating process that simultaneously achieves antibiotic immobilization, controlled release, and osteoinduction. This merging of functions into one process step reduces manufacturing complexity while maintaining therapeutic efficacy.
Solution Approach 2:
The coating system is designed to be universal and multifunctional, working effectively across different implant types and geometries. The single-process approach can be applied to various implant surfaces without requiring complex customization, making it highly adaptable for industrial production.
3Object-affected harmful factors
If antibiotic release systems are implemented, then periprosthetic infection risk is reduced, but osteointegration properties are not enhanced
Solution Approach 1:
The patent employs composite material structures combining antibiotic-loaded polymers with osteoinductive materials such as bone morphogenetic proteins or hydroxyapatite. This composite approach allows simultaneous achievement of antibacterial protection and enhanced osteointegration through the synergistic properties of the combined materials.
Solution Approach 2:
The coating is applied preliminarily to the implant surface before implantation, establishing both antibacterial and osteoinductive properties in advance. This preliminary action ensures that the surface is pre-conditioned to prevent infection and promote bone growth from the moment of implantation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process provides a multifunctional surface with enhanced osteointegration and antibacterial protection, reducing the risk of periprosthetic infections by maintaining a prolonged antibiotic effect and promoting rapid bone tissue regeneration.
Implementation Method 1
Without being restricted to a particular theory, it is deemed that this behaviour is at least partly due to the ionic interaction between the negative charges present in the molecule of hyaluronic acid and the positively charged amino groups of vancomycin.
Implementation Method 2
the bond of the molecule of hyaluronic acid to a suitably functionalised surface (with methods known in literature); then, the surface coated with hyaluronic acid is incubated in an aqueous solution of vancomycin in presence of cross-linking agents
Implementation Method 3
there is a high local concentration of a drug firmly bonded to the interface between the implant device and the external environment. This stable pharmacological barrier prevents the formation of bacterial colonies on the surface of the implant device
Data Source
AI summary
Implantable devices having antibacterial activity for preventing periprosthetic infections and for improving osteointegration capacity are provided. Methods for making and using such devices are also provided.